Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003). (Q43648005)
Jump to navigation
Jump to search
scientific article published in July 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003). |
scientific article published in July 2001 |
Statements
1 reference
Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003). (English)
1 reference
Gertz MA
1 reference
Dhodapkar MV
1 reference
Jacobson JL
1 reference
Rivkin SE
1 reference
Roodman GD
1 reference
Tuscano JM
1 reference
Shurafa M
1 reference
Kyle RA
1 reference
Crowley JJ
1 reference
Barlogie B
1 reference
1 July 2001
1 reference
1 reference
98
1 reference
1
1 reference
41-48
1 reference
Identifiers
1 reference
1 reference